ProCE Banner Activity


Applying the Expanding Range of Options for Advanced Gastric Cancer

PCE On Demand Live Presentation

The standard of care for advanced gastric cancer has evolved considerably in recent years, with many patients now optimally receiving immunotherapy or targeted therapy as part of their treatment. As such, there is a need for education on treatment selection, sequencing, and treatment-related adverse event (TRAE) management to optimize patient outcomes. This activity provides expert advice on contemporary treatment for advanced gastric cancer, with a focus on supporting data and adverse event recognition and management with novel regimens.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: December 28, 2022

Expiration: December 27, 2023

No longer available for credit.



Steven Maron

Steven Maron, MD

Assistant Attending Physician
Gastrointestinal Medical Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Kathleen Madden

Kathleen Madden, MSN, ANP-BC, AOCNP

Melanoma Program
NYU Langone Perlmutter Cancer Center
New York, NY

Provided by

ProCE Banner


This activity is supported by an educational grant from

Bristol Myers Squibb

Target Audience

Oncology NPs, PAs, and nurses

Learning Objectives

After completing this activity, participants should be better able to:

  • Individualize treatment strategies for patients with gastric cancer based on molecular testing, guideline recommendations, clinical trial evidence, and patient and disease factors 

  • Apply management strategies to adverse events associated with novel therapies 

  • Integrate patient education and feedback to optimize patient experiences during treatment and survivorship


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Kathleen Madden, MSN: consultant/advisor/speaker: Novartis.

Steven Maron, MD: consultant/stock ownership: Amgen, Basilea, Bicara, Calithera, Daiichi Sankyo, Natera, Novartis; researcher: Epic Sciences, Genentech, Guardant Health.

The planners and content peer reviewers from Partners for Advancing Clinical Education and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.

Instructions for Credit

Learners wishing to earn CE/CME credit must: 

  1. View the content in its entirety
  2. Relate the content material to the learning objectives 
  3. Complete evaluation form 

The estimated time to complete this activity is 1.00 hour.

Release date: December 28, 2022
Expiration date: Decemeber 27, 2023


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange, Partners for Advancing Clinical Education, or any educational supporter.


Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit


AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until December 27, 2023. PAs should only claim credit commensurate with the extent of their participation.


IPCE Credit Designation
IPCE This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.